<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02577692</url>
  </required_header>
  <id_info>
    <org_study_id>eN-2015-1.0</org_study_id>
    <nct_id>NCT02577692</nct_id>
  </id_info>
  <brief_title>Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers</brief_title>
  <official_title>Impact of Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers: A Randomized Controlled Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum der Universitaet Muenchen, Grosshadern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Airbus Defence and Space</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DLR German Aerospace Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum der Universitaet Muenchen, Grosshadern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High inspiratory oxygen fractions are known to induce oxidative stress and lipid&#xD;
      peroxidation. The degrading products of oxidative stress induced lipid peroxidation are in&#xD;
      part volatile and appear in breath where they can be measured non-invasively. However, there&#xD;
      is lack of knowledge on the correlation of blood and breath biomarkers of oxidative stress.&#xD;
&#xD;
      This study aims to investigate the effects of a high inspiratory oxygen fraction on oxidative&#xD;
      stress in healthy volunteers. The primary outcome is the appearance of exhaled breath&#xD;
      biomarkers of oxidative stress by electrochemical sensors and ion mobility mass spectrometry.&#xD;
      Secondary outcomes are changes in oxidative stress biomarkers in blood and their relationship&#xD;
      to breath biomarkers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in exhaled breath oxidative stress biomarker</measure>
    <time_frame>1, 4, and 24 hour</time_frame>
    <description>Measurement of oxidative stress biomarkers in breath e.g. acetaldehyde, ethan, malondialdheyde, propionaldehyde, pentane</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood oxidative stress biomarkers</measure>
    <time_frame>1, 4, and 24 hour</time_frame>
    <description>Measurement of oxidative stress biomarkers in blood e.g. ethane, malondialdehyde, pentane, propionaldheyde, total oxidative and antioxidative capacity, glutathione</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 1: breathing of 100% oxygen; Day 2: ambient air breathing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ambient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 1: breathing of 100% oxygen; Day 2: ambient air breathing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>breathing oxygen</description>
    <arm_group_label>Ambient</arm_group_label>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ambient</intervention_name>
    <description>breathing ambient air</description>
    <arm_group_label>Ambient</arm_group_label>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy male volunteers who have given an oral and written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoker or ex-smoker&#xD;
&#xD;
          -  any pulmonary disease&#xD;
&#xD;
          -  any heart disease&#xD;
&#xD;
          -  any chemotherapy in the past&#xD;
&#xD;
          -  any kind of daily medication&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael E Dolch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Universitaet Muenchen - Campus Grosshadern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Aneshtesiology, University Hospital of Munich</name>
      <address>
        <city>Muenchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2015</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum der Universitaet Muenchen, Grosshadern</investigator_affiliation>
    <investigator_full_name>Michael Dolch</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

